Diabest Botanical Drugs

Botanical Dietary Supplement to Support Blood Glucose Levels

Health Tech & Life Sciences
Non Active, Sep 2023 ceased to operate
Seed Ari'el Founded 2011
LinkedIn
Total raised
Stage
Seed
Founded
2011
Headcount
1-10
HQ
Ari'el
Sector
Health Tech & Life Sciences

About

Diabest Botanical Drugs has developed a dietary supplement to support blood glucose levels, based on Sarcopoterium spinosum extract to treat metabolic diseases. The company's treatment integrates a proprietary botanical extract method and optimized growing protocol for S. spinosum to maintain healthy blood sugar levels and avoid diabetic complications. Diabest's R&D has found that S. spinosum root extract exerts a significant anti-diabetic effect in mice. Other R&D activities include plant harvesting and production of dry extract and capsulation, optimization of growing protocol, and the characterization of S. spinosum ecotypes to generate increased biological activity. While focused on type-2 diabetes, the technology could potentially treat a wide range of metabolic disorders.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue EngineeringDrugs Discovery & Development
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesHealthcarePatientsLife SciencesPharmaceuticalsBiotechnology
Business model
B2B

Highlights

1 Patents

Tags

diabetestype-2-diabetesnatural-active-ingredientsherbal-medicinechronic-patients